Citigroup »

Inmune Bio Ord shares owned by Citigroup

Quarter-by-quarter ownership of Inmune Bio Ord (INMB) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Inmune Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Inmune Bio Ord held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmune Bio Ord by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $404k 36k 11.26
2021-03-31 $23k 1.9k 12.05

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf (EEM)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Broadcom (AVGO)

View all positions for Citigroup

Top funds holding Inmune Bio Ord

Vanguard Group
Janney Montgomery Scott
Deutsche Bank Aktiengesellschaft
MAI Wealth Advisors
Quadrant Capital
Royal Bank of Canada
Citadel Advisors
UBS Group
Jane Street
Citigroup
Westside Investment Management
Fermata Advisors
Bank of New York Mellon
Millennium Management
Balyasny Asset Management

View all funds holding Inmune Bio Ord